Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL

NCT06793189

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Shanghai Ruijin Hospital Shanghai, China
  • Affiliated First Hospital of China Medical University Shenyang, Liaoning, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

NCT04998669

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Florida Cancer Specialists and Research Institute Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Recruiting

Phase IB/II of CPX-351 for Relapse Prevention in AML

NCT04990102

Conditions
Acute Myeloid Leukemia (AML) in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

NCT06919224

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Washington University St. Louis St Louis, Missouri, United States
  • The Ohio State University Medical Center Columbus, Ohio, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Recruiting

Monitoring of Anti-TFPI in Hemophilia

NCT07101926

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique Bron, France
  • Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso Paris, France
View Trial Details
Recruiting

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

NCT05477563

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital New York, United States
  • Levine Children's Hospital - Hematology Charlotte, North Carolina, United States
  • TriStar Medical Group Children's Specialists - Pediatric Oncology Nashville, Tennessee, United States
  • University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology Düsseldorf, Germany
View Trial Details

Related conditions